Limit by date

Using a microarray (left), InfectoGnostics researchers can simultaneously detect antibodies against SARS-CoV-2 (right) and against other infectious agents. (Illustration: InfectoGnostics/BioRender.com)

Test Platform from Thuringia Checks Vaccination Status for Corona, Measles, Diphtheria & Tetanus simultaneously

Scientists at the InfectoGnostics Research Campus Jena have developed a new microarray that can detect antibodies against a wide range of infectious agents. With a single drop of the patient's blood, it is thus possible to test whether the immune system has responded to a vaccination or if there is…

Read more
Wissenschaftler der fzmb GmbH betrachten mehrere "INTER-ARRAY"-Chips. Im Hintergrund ist ein solcher Microarray in Nahaufnahme bei der Auswertung zu sehen. (Foto: fzmb)

INTER-ARRAY test kit can differentiate more than 700 strains of Staphylococcus aureus

InfectoGnostics researchers have developed a test that can detect genetic characteristics of the bacterium Staphylococcus aureus and distinguish between more than 700 strains of this pathogen. Virulence factors and resistance genes, including those of the "multiresistant" variants (MRSA), can be…

Read more

InfectoGnostics and partners at the AMR Conference 2022 in Basel (Switzerland)

Together with its partners, the InfectoGnostics Research Campus participated in the AMR Conference in Basel from April 7 to 8, 2022 and presented scientific results and cooperation concepts from Jena. The AMR Conference is considered one of the most important international conferences that…

Read more

Facilitating microbiome analyses: InfectoGnostics researchers remove irrelevant DNA already during sequencing

InfectoGnostics researchers at Jena University Hospital (JUH) and the Leibniz Institute for Photonic Technology (Leibniz-IPHT) have been able to show how irrelevant human DNA can be sorted out already during sequencing with nanopore systems to enable more precise analyses of microbiomes and bring…

Read more
A positive PVL rapid test after being carried out in the laboratory of the InfectoGnostics research campus in Jena.

Staphylococcus aureus: Rapid test detects important virulence factor "PVL" in 15 minutes

InfectoGnostics scientists at the Leibniz Institute of Photonic Technologies (Leibniz-IPHT), together with partners from the United Arab Emirates (UAE), have successfully validated a lateral flow test that was previously developed together with InfectoGnostics' corporate partners Senova and fzmb. In…

Read more

Cross-Cluster Weeks Thuringia provide impulses for innovation

The Cross-Cluster Weeks Thuringia were again a complete success in 2021 with almost 800 participants. Topics like sustainable production, new materials, energy transition, resource efficiency, on-site analysis and therapy of infections or digitalization were discussed in a cross-sectoral exchange…

Read more
[Translate to English:]

Corona Genome Sequencing: Central German Company "nanozoo" Launches Portal for Free Data Analysis

The central German start-up company "nanozoo" – a member of the InfectoGnostics research campus in Jena – has launched a portal for the free analysis and processing of raw data from the genome sequencing of SARS-CoV-2 isolates. Within a few hours, the data of registered users will be processed and…

Read more

Antibody Test for Coronavirus Developed with InfectoGnostics Partners in Jena and Weimar

An international team of researchers, including two InfectoGnostics partners - the Leibniz Institute for Photonic Technologies (Leibniz-IPHT) in Jena and the diagnostics company Senova in Weimar - has developed a rapid antibody test for the new coronavirus. Using a blood sample, it shows within ten…

Read more

InfectoGnostics Clinician Interviewed: Precision Medicine 2.0

The right treatment for the right patient at the right time - this approach of "precision medicine" is increasingly being used in the prevention of infections and sepsis. In an interview with the "Infectious Diseases Hub", Prof. Mathias Pletz, leading infectiologist at the University Hospital of…

Read more

New Leibniz research centre in Jena: Photonics for the fight against resistant pathogens

The Federal Ministry of Education and Research (BMBF) is funding a new Leibniz Research Centre in Jena. Technology developers, physicians and medical technology manufacturers will bring light-based technologies for better diagnostics and therapy of infections from the idea to the application in the…

Read more